Systemic immunosuppressive therapies for uveitis in developing countries
Mudit Tyagi(L V Prasad Eye Institute), Sujata Sawhney(Sir Ganga Ram Hospital), Veena Sangwan(Dr. Shroff’s Charity Eye Hospital), Manohar Babu(Aravind Eye Hospital), Hien Van Doan(Chiang Mai University), Peter McCluskey(The George Institute for Global Health), Brandon Pham(Horizon Therapeutics (United States)), QuanDong Nguyen(L V Prasad Eye Institute), Hitesh Agrawal(L V Prasad Eye Institute), Amit Khosla(L V Prasad Eye Institute), Subhakar Reddy(L V Prasad Eye Institute)
Cited by 28
Related Papers
TFOS DEWS II iatrogenic report
|The Ocular Surface|2017|444
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Probiotic application for sustainable aquaculture
|Reviews in Aquaculture|2018|409